Annual CFI:
-$129.29M+$290.78M(+69.22%)Summary
- As of today, ARWR annual cash from investing is -$129.29 million, with the most recent change of +$290.78 million (+69.22%) on September 30, 2025.
- During the last 3 years, ARWR annual cash from investing has fallen by -$123.88 million (-2286.82%).
- ARWR annual cash from investing is now -1015.63% below its all-time high of $14.12 million, reached on September 30, 2015.
Performance
ARWR Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly CFI:
$72.62M-$68.77M(-48.64%)Summary
- As of today, ARWR quarterly cash from investing is $72.62 million, with the most recent change of -$68.77 million (-48.64%) on September 30, 2025.
- Over the past year, ARWR quarterly cash from investing has increased by +$295.54 million (+132.58%).
- ARWR quarterly cash from investing is now -48.64% below its all-time high of $141.39 million, reached on June 30, 2025.
Performance
ARWR Quarterly Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFI:
-$129.29M+$295.54M(+69.57%)Summary
- As of today, ARWR TTM cash from investing is -$129.29 million, with the most recent change of +$295.54 million (+69.57%) on September 30, 2025.
- Over the past year, ARWR TTM cash from investing has increased by +$290.78 million (+69.22%).
- ARWR TTM cash from investing is now -361.85% below its all-time high of $49.38 million, reached on December 31, 2023.
Performance
ARWR TTM Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash From Investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
ARWR Cash From Investing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | +69.2% | +132.6% | +69.2% |
| 3Y3 Years | -2286.8% | +99.3% | -2286.8% |
| 5Y5 Years | +46.3% | +210.2% | +46.3% |
ARWR Cash From Investing Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -2286.8% | +69.2% | -48.6% | +117.3% | -361.9% | +76.9% |
| 5Y | 5-Year | -2286.8% | +69.2% | -48.6% | +117.3% | -361.9% | +76.9% |
| All-Time | All-Time | -1015.6% | +69.2% | -48.6% | +117.3% | -361.9% | +76.9% |
ARWR Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2025 | -$129.29M(+69.2%) | $72.62M(-48.6%) | -$129.29M(+69.6%) |
| Jun 2025 | - | $141.39M(+133.6%) | -$424.84M(+24.0%) |
| Mar 2025 | - | -$420.21M(-646.4%) | -$559.28M(-37.1%) |
| Dec 2024 | - | $76.91M(+134.5%) | -$408.00M(+2.9%) |
| Sep 2024 | -$420.07M(-336.9%) | -$222.92M(-3308.0%) | -$420.07M(-152.1%) |
| Jun 2024 | - | $6.95M(+102.6%) | -$166.64M(+9.2%) |
| Mar 2024 | - | -$268.94M(-514.8%) | -$183.49M(-471.6%) |
| Dec 2023 | - | $64.84M(+112.5%) | $49.38M(+151.4%) |
| Sep 2023 | -$96.16M(-1675.1%) | $30.51M(+408.0%) | -$96.16M(-6.6%) |
| Jun 2023 | - | -$9.90M(+72.5%) | -$90.22M(-373.9%) |
| Mar 2023 | - | -$36.06M(+55.3%) | -$19.04M(+63.9%) |
| Dec 2022 | - | -$80.69M(-321.4%) | -$52.73M(-873.3%) |
| Sep 2022 | -$5.42M(+96.2%) | $36.45M(-40.5%) | -$5.42M(+96.6%) |
| Jun 2022 | - | $61.28M(+187.8%) | -$160.11M(+33.5%) |
| Mar 2022 | - | -$69.75M(-108.9%) | -$240.93M(-17.4%) |
| Dec 2021 | - | -$33.38M(+71.8%) | -$205.22M(-44.9%) |
| Sep 2021 | -$141.68M(+41.2%) | -$118.25M(-505.1%) | -$141.68M(-58.6%) |
| Jun 2021 | - | -$19.54M(+42.6%) | -$89.33M(-17.8%) |
| Mar 2021 | - | -$34.05M(-212.9%) | -$75.82M(+65.5%) |
| Dec 2020 | - | $30.16M(+145.8%) | -$219.90M(+8.7%) |
| Sep 2020 | -$240.78M(-404.3%) | -$65.89M(-992.1%) | -$240.78M(-52.3%) |
| Jun 2020 | - | -$6.03M(+96.6%) | -$158.05M(-14.8%) |
| Mar 2020 | - | -$178.13M(-2019.4%) | -$137.62M(-569.9%) |
| Dec 2019 | - | $9.28M(-44.9%) | $29.29M(+161.3%) |
| Sep 2019 | -$47.75M(-542.2%) | $16.83M(+16.9%) | -$47.75M(+22.1%) |
| Jun 2019 | - | $14.40M(+228.4%) | -$61.33M(+41.4%) |
| Mar 2019 | - | -$11.22M(+83.4%) | -$104.58M(-36.6%) |
| Dec 2018 | - | -$67.76M(-2186.7%) | -$76.55M(-929.6%) |
| Sep 2018 | -$7.43M(+84.7%) | $3.25M(+111.3%) | -$7.43M(+50.1%) |
| Jun 2018 | - | -$28.85M(-271.6%) | -$14.90M(-1549.9%) |
| Mar 2018 | - | $16.82M(+1139.2%) | $1.03M(+102.4%) |
| Dec 2017 | - | $1.36M(+132.2%) | -$41.99M(+13.7%) |
| Sep 2017 | -$48.64M(-461.7%) | -$4.22M(+67.4%) | -$48.64M(-5.4%) |
| Jun 2017 | - | -$12.93M(+50.7%) | -$46.14M(-94.3%) |
| Mar 2017 | - | -$26.20M(-394.7%) | -$23.75M(-527.4%) |
| Dec 2016 | - | -$5.30M(-209.3%) | $5.56M(-58.7%) |
| Sep 2016 | $13.45M(-4.8%) | -$1.71M(-118.1%) | $13.45M(-36.0%) |
| Jun 2016 | - | $9.46M(+204.6%) | $21.01M(+35.3%) |
| Mar 2016 | - | $3.11M(+19.8%) | $15.52M(-26.8%) |
| Dec 2015 | - | $2.59M(-55.6%) | $21.21M(+50.2%) |
| Sep 2015 | $14.12M(+138.7%) | $5.84M(+47.0%) | $14.12M(+10.1%) |
| Jun 2015 | - | $3.98M(-54.8%) | $12.82M(+31.1%) |
| Mar 2015 | - | $8.80M(+295.5%) | $9.78M(+137.9%) |
| Dec 2014 | - | -$4.50M(-199.0%) | -$25.84M(+29.2%) |
| Sep 2014 | -$36.48M(-283.2%) | $4.54M(+385.4%) | -$36.48M(+23.3%) |
| Jun 2014 | - | $936.40K(+103.5%) | -$47.55M(+9.8%) |
| Mar 2014 | - | -$26.82M(-77.1%) | -$52.74M(-112.9%) |
| Dec 2013 | - | -$15.15M(-132.3%) | -$24.78M(-160.3%) |
| Sep 2013 | -$9.52M(-2260.9%) | -$6.52M(-53.1%) | -$9.52M(-237.4%) |
| Jun 2013 | - | -$4.26M(-471.6%) | -$2.82M(-307.5%) |
| Mar 2013 | - | $1.15M(+923.1%) | $1.36M(>+9900.0%) |
| Dec 2012 | - | $112.00K(-37.2%) | $13.40K(-97.0%) |
| Sep 2012 | $440.60K | $178.40K(+334.4%) | $440.60K(-33.9%) |
| Jun 2012 | - | -$76.10K(+62.1%) | $666.20K(-45.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2012 | - | -$200.90K(-137.3%) | $1.22M(-53.5%) |
| Dec 2011 | - | $539.20K(+33.5%) | $2.63M(+25.8%) |
| Sep 2011 | -$175.40K(-136.0%) | $404.00K(-15.8%) | $2.09M(+18.6%) |
| Jun 2011 | - | $479.90K(-60.2%) | $1.76M(+38.0%) |
| Mar 2011 | - | $1.21M(>+9900.0%) | $1.28M(+1702.5%) |
| Dec 2010 | - | $0.00(-100.0%) | $70.80K(-85.4%) |
| Sep 2010 | $487.60K(-34.0%) | $75.70K(+1476.4%) | $485.00K(+25.7%) |
| Jun 2010 | - | -$5500.00(-1016.7%) | $385.70K(-10.6%) |
| Mar 2010 | - | $600.00(-99.9%) | $431.50K(-10.4%) |
| Dec 2009 | - | $414.20K(+1855.1%) | $481.50K(-34.9%) |
| Sep 2009 | $739.10K(+128.7%) | -$23.60K(-158.6%) | $739.20K(+107.1%) |
| Jun 2009 | - | $40.30K(-20.4%) | -$10.43M(-22.5%) |
| Mar 2009 | - | $50.60K(-92.5%) | -$8.51M(+2.7%) |
| Dec 2008 | - | $671.90K(+106.0%) | -$8.75M(-239.8%) |
| Sep 2008 | -$2.57M(-158.8%) | -$11.19M(-672.0%) | -$2.57M(-130.6%) |
| Jun 2008 | - | $1.96M(+1141.0%) | $8.42M(+39.1%) |
| Mar 2008 | - | -$187.90K(-102.7%) | $6.05M(-2.4%) |
| Dec 2007 | - | $6.85M(+3652.7%) | $6.21M(+41.7%) |
| Sep 2007 | $4.38M(+908.1%) | -$192.70K(+53.1%) | $4.38M(-77.1%) |
| Jun 2007 | - | -$410.60K(-992.0%) | $19.16M(-17.6%) |
| Mar 2007 | - | -$37.60K(-100.7%) | $23.25M(+399.4%) |
| Dec 2006 | - | $5.02M(-65.6%) | $4.66M(+959.0%) |
| Sep 2006 | -$542.00K(-123.9%) | $14.58M(+295.6%) | -$542.00K(+96.4%) |
| Jun 2006 | - | $3.69M(+119.8%) | -$15.23M(+20.4%) |
| Mar 2006 | - | -$18.63M(>-9900.0%) | -$19.12M(-970.5%) |
| Dec 2005 | - | -$177.20K(-72.7%) | $2.20M(-3.2%) |
| Sep 2005 | $2.27M(+731.1%) | -$102.60K(+50.8%) | $2.27M(+17.7%) |
| Jun 2005 | - | -$208.60K(-107.8%) | $1.93M(-13.5%) |
| Mar 2005 | - | $2.69M(+2664.7%) | $2.23M(+580.1%) |
| Dec 2004 | - | -$104.70K(+76.4%) | -$464.30K(-29.1%) |
| Sep 2004 | -$359.60K(>-9900.0%) | -$443.50K(-582.1%) | -$359.60K(-539.6%) |
| Jun 2004 | - | $92.00K(+1235.8%) | $81.80K(+902.0%) |
| Mar 2004 | - | -$8100.00(>-9900.0%) | -$10.20K(-385.7%) |
| Dec 2003 | - | $0.00(+100.0%) | -$2100.00(0.0%) |
| Sep 2003 | -$2100.00(-23.5%) | -$2100.00(>-9900.0%) | -$2100.00(>-9900.0%) |
| Jun 2003 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2003 | - | $0.00(0.0%) | $0.00(+100.0%) |
| Dec 2002 | - | $0.00(0.0%) | -$1700.00(0.0%) |
| Sep 2002 | -$1700.00(>-9900.0%) | $0.00(0.0%) | -$1700.00(0.0%) |
| Jun 2002 | - | $0.00(+100.0%) | -$1700.00(0.0%) |
| Mar 2002 | - | -$1700.00(>-9900.0%) | -$1700.00(>-9900.0%) |
| Dec 2001 | - | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2001 | $0.00(+100.0%) | $0.00(0.0%) | $0.00(0.0%) |
| Jun 2001 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2001 | - | $0.00(0.0%) | $0.00(0.0%) |
| Dec 2000 | - | $0.00(0.0%) | $0.00(+100.0%) |
| Sep 2000 | -$700.00(>-9900.0%) | $0.00(0.0%) | -$700.00(0.0%) |
| Jun 2000 | - | $0.00(0.0%) | -$700.00(0.0%) |
| Mar 2000 | - | $0.00(+100.0%) | -$700.00(0.0%) |
| Dec 1999 | - | -$700.00(>-9900.0%) | -$700.00(>-9900.0%) |
| Sep 1999 | $0.00(0.0%) | $0.00(0.0%) | $0.00(0.0%) |
| Jun 1999 | - | $0.00 | $0.00 |
| Sep 1998 | $0.00(0.0%) | - | - |
| Sep 1997 | $0.00 | - | - |
FAQ
- What is Arrowhead Pharmaceuticals, Inc. annual cash from investing?
- What is the all-time high annual cash from investing for Arrowhead Pharmaceuticals, Inc.?
- What is Arrowhead Pharmaceuticals, Inc. annual cash from investing year-on-year change?
- What is Arrowhead Pharmaceuticals, Inc. quarterly cash from investing?
- What is the all-time high quarterly cash from investing for Arrowhead Pharmaceuticals, Inc.?
- What is Arrowhead Pharmaceuticals, Inc. quarterly cash from investing year-on-year change?
- What is Arrowhead Pharmaceuticals, Inc. TTM cash from investing?
- What is the all-time high TTM cash from investing for Arrowhead Pharmaceuticals, Inc.?
- What is Arrowhead Pharmaceuticals, Inc. TTM cash from investing year-on-year change?
What is Arrowhead Pharmaceuticals, Inc. annual cash from investing?
The current annual cash from investing of ARWR is -$129.29M
What is the all-time high annual cash from investing for Arrowhead Pharmaceuticals, Inc.?
Arrowhead Pharmaceuticals, Inc. all-time high annual cash from investing is $14.12M
What is Arrowhead Pharmaceuticals, Inc. annual cash from investing year-on-year change?
Over the past year, ARWR annual cash from investing has changed by +$290.78M (+69.22%)
What is Arrowhead Pharmaceuticals, Inc. quarterly cash from investing?
The current quarterly cash from investing of ARWR is $72.62M
What is the all-time high quarterly cash from investing for Arrowhead Pharmaceuticals, Inc.?
Arrowhead Pharmaceuticals, Inc. all-time high quarterly cash from investing is $141.39M
What is Arrowhead Pharmaceuticals, Inc. quarterly cash from investing year-on-year change?
Over the past year, ARWR quarterly cash from investing has changed by +$295.54M (+132.58%)
What is Arrowhead Pharmaceuticals, Inc. TTM cash from investing?
The current TTM cash from investing of ARWR is -$129.29M
What is the all-time high TTM cash from investing for Arrowhead Pharmaceuticals, Inc.?
Arrowhead Pharmaceuticals, Inc. all-time high TTM cash from investing is $49.38M
What is Arrowhead Pharmaceuticals, Inc. TTM cash from investing year-on-year change?
Over the past year, ARWR TTM cash from investing has changed by +$290.78M (+69.22%)